ReP USP - Resultado da busca

Artigo de periodico
Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors (2023)
Macedo, Mariana Petaccia de; Nascimento, Ellen Caroline Toledo; Santini, Fernando Costa; Soares, Fernando Augusto ; Costa, Felipe D’Almeida; Cunha, Isabela Werneck da; Munhoz, Rodrigo Ramella; Marchi, Pedro De; Jorge, Thiago William Carnier; Leite, Katia Ramos Moreira
Fonte: Clinical Pathology. Unidades: FO, FM
Assuntos: BIOMARCADORES, RECOMBINAÇÃO GENÉTICA, BIOLOGIA MOLECULAR, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Mariana Petaccia de et al. Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors. Clinical Pathology, v. 16, n. Ja/Dec. 2023, 2023Tradução . . Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/. Acesso em: 30 jun. 2024.
APA
Macedo, M. P. de, Nascimento, E. C. T., Santini, F. C., Soares, F. A., Costa, F. D. ’A., Cunha, I. W. da, et al. (2023). Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors. Clinical Pathology, 16( Ja/Dec. 2023). doi:10.1177/2632010X23119708
NLM
Macedo MP de, Nascimento ECT, Santini FC, Soares FA, Costa FD’A, Cunha IW da, Munhoz RR, Marchi PD, Jorge TWC, Leite KRM. Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors [Internet]. Clinical Pathology. 2023 ; 16( Ja/Dec. 2023):[citado 2024 jun. 30 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/
Vancouver
Macedo MP de, Nascimento ECT, Santini FC, Soares FA, Costa FD’A, Cunha IW da, Munhoz RR, Marchi PD, Jorge TWC, Leite KRM. Brazilian Expert Consensus for NTRK Gene Fusion Testing in Solid Tumors [Internet]. Clinical Pathology. 2023 ; 16( Ja/Dec. 2023):[citado 2024 jun. 30 ] Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10504829/
Artigo de periodico
Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups From 2010 to 2019 a systematic analysis for the global burden of disease study 2019 (2022)
Kocarnik, Jonathan M; Compton, Kelly; Dean, Frances E; Fu, Weijia; Gaw, Brian L; Harvey, James D; Henrikson, Hannah Jacqueline; Lu, Dan; Pennini, Alyssa; Alonso, Nivaldo
Fonte: Jama oncology. Unidade: FM
Assuntos: VIGILÂNCIA SANITÁRIA, NEOPLASIAS, COVID-19, ESTATÍSTICAS VITAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOCARNIK, Jonathan M et al. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups From 2010 to 2019 a systematic analysis for the global burden of disease study 2019. Jama oncology, v. 8, n. 3, p. 420-444, 2022Tradução . . Disponível em: https://doi.org/10.1001/jamaoncol.2021.6987. Acesso em: 30 jun. 2024.
APA
Kocarnik, J. M., Compton, K., Dean, F. E., Fu, W., Gaw, B. L., Harvey, J. D., et al. (2022). Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups From 2010 to 2019 a systematic analysis for the global burden of disease study 2019. Jama oncology, 8( 3), 420-444. doi:10.1001/jamaoncol.2021.6987
NLM
Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Alonso N. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups From 2010 to 2019 a systematic analysis for the global burden of disease study 2019 [Internet]. Jama oncology. 2022 ; 8( 3): 420-444.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1001/jamaoncol.2021.6987
Vancouver
Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, Harvey JD, Henrikson HJ, Lu D, Pennini A, Alonso N. Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups From 2010 to 2019 a systematic analysis for the global burden of disease study 2019 [Internet]. Jama oncology. 2022 ; 8( 3): 420-444.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1001/jamaoncol.2021.6987
Artigo de periodico
The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019 (2022)
Khanh Bao Tran; Lang, Justin J; Compton, Kelly; Xu, Rixing; Acheson, Alistair R; Henrikson, Hannah Jacqueline; Kocarnik, Jonathan M; Penberthy, Louise; Aali, Amirali; Alonso, Nivaldo
Fonte: Lancet. Unidade: FM
Assuntos: CONSENSO, NEOPLASIAS, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KHANH BAO TRAN, et al. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, v. 400, n. 10352, p. 563-591, 2022Tradução . . Disponível em: https://doi.org/10.1016/S0140-6736(22)01438-6. Acesso em: 30 jun. 2024.
APA
Khanh Bao Tran,, Lang, J. J., Compton, K., Xu, R., Acheson, A. R., Henrikson, H. J., et al. (2022). The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 400( 10352), 563-591. doi:10.1016/S0140-6736(22)01438-6
NLM
Khanh Bao Tran, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Alonso N. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019 [Internet]. Lancet. 2022 ; 400( 10352): 563-591.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/S0140-6736(22)01438-6
Vancouver
Khanh Bao Tran, Lang JJ, Compton K, Xu R, Acheson AR, Henrikson HJ, Kocarnik JM, Penberthy L, Aali A, Alonso N. The global burden of cancer attributable to risk factors, 2010-19: a systematic analysis for the Global Burden of Disease Study 2019 [Internet]. Lancet. 2022 ; 400( 10352): 563-591.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/S0140-6736(22)01438-6
Artigo de periodico
Oral Squamous Cell Carcinoma Bone Invasion: possible Roles of E-Cadherin in Osteoclastogenesis and Bone Infiltration (2021)
Koyama, Leonardo Kenji Sakaue; Nagano, Cibele Pidorodeski; Vanini, Jaqueline Vaz; Figueredo Junior, José Martins; Matos, Leandro Luongo de; Cernea, Claudio Roberto ; Camillo, Cláudia Malheiros Coutinho; Lourenço, Sílvia Vanessa
Fonte: ORL. Unidades: FO, FM, BIOTECNOLOGIA
Assuntos: CARCINOMA DE CÉLULAS ESCAMOSAS, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KOYAMA, Leonardo Kenji Sakaue et al. Oral Squamous Cell Carcinoma Bone Invasion: possible Roles of E-Cadherin in Osteoclastogenesis and Bone Infiltration. ORL, v. 83, n. 5, 2021Tradução . . Disponível em: https://doi.org/10.1159/000514229. Acesso em: 30 jun. 2024.
APA
Koyama, L. K. S., Nagano, C. P., Vanini, J. V., Figueredo Junior, J. M., Matos, L. L. de, Cernea, C. R., et al. (2021). Oral Squamous Cell Carcinoma Bone Invasion: possible Roles of E-Cadherin in Osteoclastogenesis and Bone Infiltration. ORL, 83( 5). doi:10.1159/000514229
NLM
Koyama LKS, Nagano CP, Vanini JV, Figueredo Junior JM, Matos LL de, Cernea CR, Camillo CMC, Lourenço SV. Oral Squamous Cell Carcinoma Bone Invasion: possible Roles of E-Cadherin in Osteoclastogenesis and Bone Infiltration [Internet]. ORL. 2021 ; 83( 5):[citado 2024 jun. 30 ] Available from: https://doi.org/10.1159/000514229
Vancouver
Koyama LKS, Nagano CP, Vanini JV, Figueredo Junior JM, Matos LL de, Cernea CR, Camillo CMC, Lourenço SV. Oral Squamous Cell Carcinoma Bone Invasion: possible Roles of E-Cadherin in Osteoclastogenesis and Bone Infiltration [Internet]. ORL. 2021 ; 83( 5):[citado 2024 jun. 30 ] Available from: https://doi.org/10.1159/000514229
Artigo de periodico
High levels of modified ceramides are a defining feature of murine and human cancer cachexia (2020)
Morigny, Pauline; Zuber, Julia; Haid, Mark; Kaltenecker, Doris; Riols, Fabien; Lima, Joanna D. C.; Simoes, Estefania; Otoch, Jose Pinhata; Schmidt, Soeren Fisker; Herzig, Stephan
Fonte: Journal of cachexia sarcopenia and muscle. Unidade: FM
Assuntos: ANIMAIS, CAQUEXIA, CAMUNDONGOS, ATROFIA MUSCULAR, NEOPLASIAS, QUALIDADE DE VIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MORIGNY, Pauline et al. High levels of modified ceramides are a defining feature of murine and human cancer cachexia. Journal of cachexia sarcopenia and muscle, v. 11, n. 6, p. 1459-1475, 2020Tradução . . Disponível em: https://doi.org/10.1002/jcsm.12626. Acesso em: 30 jun. 2024.
APA
Morigny, P., Zuber, J., Haid, M., Kaltenecker, D., Riols, F., Lima, J. D. C., et al. (2020). High levels of modified ceramides are a defining feature of murine and human cancer cachexia. Journal of cachexia sarcopenia and muscle, 11( 6), 1459-1475. doi:10.1002/jcsm.12626
NLM
Morigny P, Zuber J, Haid M, Kaltenecker D, Riols F, Lima JDC, Simoes E, Otoch JP, Schmidt SF, Herzig S. High levels of modified ceramides are a defining feature of murine and human cancer cachexia [Internet]. Journal of cachexia sarcopenia and muscle. 2020 ; 11( 6): 1459-1475.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/jcsm.12626
Vancouver
Morigny P, Zuber J, Haid M, Kaltenecker D, Riols F, Lima JDC, Simoes E, Otoch JP, Schmidt SF, Herzig S. High levels of modified ceramides are a defining feature of murine and human cancer cachexia [Internet]. Journal of cachexia sarcopenia and muscle. 2020 ; 11( 6): 1459-1475.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/jcsm.12626
Trabalho de evento-resumo periodico
Parâmetros histopatológicos associados a evolução do câncer de lábio (2019)
Barreto, A. C. M.; Freitas Filho, S. A. J.; Garcia, A. S.; Pinto, C. A. L.; Kowalski, L. P.; Oliveira, Denise Tostes
Fonte: Brazilian Oral Research. Nome do evento: Reunião Anual da Sociedade Brasileira de Pesquisa Odontológica - SBPqO. Unidades: FOB, FM
Assuntos: NEOPLASIAS, LÁBIO, HISTOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARRETO, A. C. M. et al. Parâmetros histopatológicos associados a evolução do câncer de lábio. Brazilian Oral Research. São Paulo: Faculdade de Odontologia de Bauru, Universidade de São Paulo. . Acesso em: 30 jun. 2024. , 2019
APA
Barreto, A. C. M., Freitas Filho, S. A. J., Garcia, A. S., Pinto, C. A. L., Kowalski, L. P., & Oliveira, D. T. (2019). Parâmetros histopatológicos associados a evolução do câncer de lábio. Brazilian Oral Research. São Paulo: Faculdade de Odontologia de Bauru, Universidade de São Paulo.
NLM
Barreto ACM, Freitas Filho SAJ, Garcia AS, Pinto CAL, Kowalski LP, Oliveira DT. Parâmetros histopatológicos associados a evolução do câncer de lábio. Brazilian Oral Research. 2019 ;[citado 2024 jun. 30 ]
Vancouver
Barreto ACM, Freitas Filho SAJ, Garcia AS, Pinto CAL, Kowalski LP, Oliveira DT. Parâmetros histopatológicos associados a evolução do câncer de lábio. Brazilian Oral Research. 2019 ;[citado 2024 jun. 30 ]
Artigo de periodico
The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis (2019)
Leiderman, Dafne Braga Diamante; Zerati, Antonio Eduardo; Mariz, Maria Paula Vieira; Wolosker, Nelson ; Leao, Pedro Puech ; Luccia, Nelson De
Fonte: Annals of vascular surgery. Unidade: FM
Assuntos: VEIA CAVA, PRÓTESE VASCULAR, TROMBOSE, NEOPLASIAS, PROGNÓSTICO, SOBREVIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LEIDERMAN, Dafne Braga Diamante et al. The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis. Annals of vascular surgery, v. 60, p. 35-44, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.avsg.2018.12.085. Acesso em: 30 jun. 2024.
APA
Leiderman, D. B. D., Zerati, A. E., Mariz, M. P. V., Wolosker, N., Leao, P. P., & Luccia, N. D. (2019). The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis. Annals of vascular surgery, 60, 35-44. doi:10.1016/j.avsg.2018.12.085
NLM
Leiderman DBD, Zerati AE, Mariz MPV, Wolosker N, Leao PP, Luccia ND. The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis [Internet]. Annals of vascular surgery. 2019 ; 60 35-44.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.avsg.2018.12.085
Vancouver
Leiderman DBD, Zerati AE, Mariz MPV, Wolosker N, Leao PP, Luccia ND. The need for a vena cava filter in oncological patients with acute venous thrombosis: a marker of a worse prognosis [Internet]. Annals of vascular surgery. 2019 ; 60 35-44.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.avsg.2018.12.085
Artigo de periodico
Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia (2019)
Kawahara, Rebeca; Recuero, Saulo; Nogueira, Fabio C. S. ; Domont, Gilberto B. ; Leite, Katia Ramos Moreira ; Srougi, Miguel ; Thaysen‐Andersen, Morten ; Palmisano, Giuseppe
Fonte: Proteomics. Unidades: FM, ICB
Assuntos: PARASITOLOGIA, NEOPLASIAS, PRÓSTATA, NEOPLASIAS DOS GENITAIS MASCULINOS, HIPERPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAHARA, Rebeca et al. Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia. Proteomics, v. 19, n. 21-22, p. e1900174, 2019Tradução . . Disponível em: https://doi.org/10.1002/pmic.201900174. Acesso em: 30 jun. 2024.
APA
Kawahara, R., Recuero, S., Nogueira, F. C. S., Domont, G. B., Leite, K. R. M., Srougi, M., et al. (2019). Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia. Proteomics, 19( 21-22), e1900174. doi:10.1002/pmic.201900174
NLM
Kawahara R, Recuero S, Nogueira FCS, Domont GB, Leite KRM, Srougi M, Thaysen‐Andersen M, Palmisano G. Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia [Internet]. Proteomics. 2019 ; 19( 21-22): e1900174.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/pmic.201900174
Vancouver
Kawahara R, Recuero S, Nogueira FCS, Domont GB, Leite KRM, Srougi M, Thaysen‐Andersen M, Palmisano G. Tissue proteome signatures associated with five grades of prostate cancer and benign prostatic hyperplasia [Internet]. Proteomics. 2019 ; 19( 21-22): e1900174.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/pmic.201900174
Artigo de periodico
Protein paucimannosylation is an enriched N-gycosylation signature of human cancers (2019)
Chatterjee, Sayantani ; Lee, Ling Y. ; Kawahara, Rebeca ; Abrahams, Jodie L. ; Adamczyk, Barbara ; Anugraham, Merrina ; Ashwood, Christopher ; Sumer‐Bayraktar, Zeynep ; Briggs, Matthew T. ; Chik, Jenny H. L. ; Everest‐Dass, Arun ; Förster, Sarah; Hinneburg, Hannes; Leite, Katia Ramos Moreira ; Loke, Ian ; Möginger, Uwe; Moh, Edward S. X. ; Nakano, Miyako; Recuero, Saulo; Sethi, Manveen K. ; Srougi, Miguel ; Stavenhagen, Kathrin ; Venkatakrishnan, Vignesh ; Wongtrakul‐Kish, Katherine ; Diestel, Simone ; Hoffmann, Peter; Karlsson, Niclas G. ; Kolarich, Daniel ; Molloy, Mark P. ; Muders, Michael H.; Oehler, Martin K. ; Packer, Nicolle H. ; Palmisano, Giuseppe ; Thaysen‐Andersen, Morten
Fonte: Proteomics. Unidades: FM, ICB
Assuntos: PARASITOLOGIA, NEOPLASIAS, LEUCEMIA, NEOPLASIAS HEPÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CHATTERJEE, Sayantani et al. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, p. 1-13, 2019Tradução . . Disponível em: https://doi.org/10.1002/pmic.201900010. Acesso em: 30 jun. 2024.
APA
Chatterjee, S., Lee, L. Y., Kawahara, R., Abrahams, J. L., Adamczyk, B., Anugraham, M., et al. (2019). Protein paucimannosylation is an enriched N-gycosylation signature of human cancers. Proteomics, 1-13. doi:10.1002/pmic.201900010
NLM
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/pmic.201900010
Vancouver
Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer‐Bayraktar Z, Briggs MT, Chik JHL, Everest‐Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul‐Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen‐Andersen M. Protein paucimannosylation is an enriched N-gycosylation signature of human cancers [Internet]. Proteomics. 2019 ; 1-13.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1002/pmic.201900010
Artigo de periodico
Distinct urinary glycoprotein signatures in prostate cancer patients (2018)
Kawahara, Rebeca ; Ortega, Fabio; Rosa-Fernandes, Livia ; Guimarães, Vanessa; Quina, Daniel; Nahas, Willian; Schwämmle, Veit ; Srougi, Miguel ; Leite, Katia Ramos Moreira ; Thaysen-Andersen, Morten ; Larsen, Martin R. ; Palmisano, Giuseppe
Fonte: OncoTarget. Unidades: FM, ICB
Assuntos: PARASITOLOGIA, GLICOPROTEÍNAS, NEOPLASIAS, PRÓSTATA, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KAWAHARA, Rebeca et al. Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget, 2018Tradução . . Disponível em: https://doi.org/10.18632/oncotarget.26005. Acesso em: 30 jun. 2024.
APA
Kawahara, R., Ortega, F., Rosa-Fernandes, L., Guimarães, V., Quina, D., Nahas, W., et al. (2018). Distinct urinary glycoprotein signatures in prostate cancer patients. OncoTarget. doi:10.18632/oncotarget.26005
NLM
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2024 jun. 30 ] Available from: https://doi.org/10.18632/oncotarget.26005
Vancouver
Kawahara R, Ortega F, Rosa-Fernandes L, Guimarães V, Quina D, Nahas W, Schwämmle V, Srougi M, Leite KRM, Thaysen-Andersen M, Larsen MR, Palmisano G. Distinct urinary glycoprotein signatures in prostate cancer patients [Internet]. OncoTarget. 2018 ;[citado 2024 jun. 30 ] Available from: https://doi.org/10.18632/oncotarget.26005
Artigo de periodico
Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting (2018)
Marinho, Rodolfo; Alcântara, Paulo Sérgio Martins de; Otoch, José Pinhata; Seelaender, Marília Cerqueira Leite
Fonte: Frontiers in Nutrition. Unidades: HU, FM, ICB
Assuntos: MICRORNAS, CAQUEXIA, INFLAMAÇÃO, PERDA DE MASSA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MARINHO, Rodolfo et al. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Frontiers in Nutrition, v. 4, n. ja 2018, p. 7 , 2018Tradução . . Disponível em: https://doi.org/10.3389/fnut.2017.00069. Acesso em: 30 jun. 2024.
APA
Marinho, R., Alcântara, P. S. M. de, Otoch, J. P., & Seelaender, M. C. L. (2018). Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting. Frontiers in Nutrition, 4( ja 2018), 7 . doi:10.3389/fnut.2017.00069
NLM
Marinho R, Alcântara PSM de, Otoch JP, Seelaender MCL. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting [Internet]. Frontiers in Nutrition. 2018 ; 4( ja 2018): 7 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.3389/fnut.2017.00069
Vancouver
Marinho R, Alcântara PSM de, Otoch JP, Seelaender MCL. Role of exosomal microRNAs and myomiRs in the development of cancer cachexia-associated muscle wasting [Internet]. Frontiers in Nutrition. 2018 ; 4( ja 2018): 7 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.3389/fnut.2017.00069
Artigo de periodico
Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth (2018)
Fort, Rafael Sebastián; Mathó, Cecilia; Geraldo, Murilo Vieira; Ottati, María Carolina; Yamashita, Alex Shimura; Saito, Kelly Cristina; Leite, Katia Ramos Moreira; Méndez, Manuel; Maedo, Noemí; Méndez, Laura; Garat, Beatriz; Kimura, Edna Teruko ; Silveira, José Roberto Sotelo; Duhagon, María Ana
Fonte: BMC Cancer. Unidades: ICB, FM
Assuntos: METILAÇÃO DE DNA, NEOPLASIAS, NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORT, Rafael Sebastián et al. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, v. 18, n. 1, p. 13 , 2018Tradução . . Disponível em: https://doi.org/10.1186/s12885-018-4049-7. Acesso em: 30 jun. 2024.
APA
Fort, R. S., Mathó, C., Geraldo, M. V., Ottati, M. C., Yamashita, A. S., Saito, K. C., et al. (2018). Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth. BMC Cancer, 18( 1), 13 . doi:10.1186/s12885-018-4049-7
NLM
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12885-018-4049-7
Vancouver
Fort RS, Mathó C, Geraldo MV, Ottati MC, Yamashita AS, Saito KC, Leite KRM, Méndez M, Maedo N, Méndez L, Garat B, Kimura ET, Silveira JRS, Duhagon MA. Nc886 is epigenetically repressed in prostate cancer and acts as a tumor suppressor through the inhibition of cell growth [Internet]. BMC Cancer. 2018 ; 18( 1): 13 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12885-018-4049-7
Artigo de periodico
Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center (2018)
Cavalheiro, Beatriz Godoi; Leite, Ana Kober Nogueira; Matos, Leandro Luongo de; Miazaki, Aline Palermo; Ientile, Jan Marcel; Kulcsar, Marco Aurelio V; Cernea, Claudio Roberto
Fonte: International journal of endocrinology and metabolism. Unidade: FM
Assuntos: NEOPLASIAS, CARCINOMA, DIAGNÓSTICO, CITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAVALHEIRO, Beatriz Godoi et al. Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center. International journal of endocrinology and metabolism, v. 16, n. 1, 2018Tradução . . Disponível em: https://doi.org/10.5812/ijem.12871. Acesso em: 30 jun. 2024.
APA
Cavalheiro, B. G., Leite, A. K. N., Matos, L. L. de, Miazaki, A. P., Ientile, J. M., Kulcsar, M. A. V., & Cernea, C. R. (2018). Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center. International journal of endocrinology and metabolism, 16( 1). doi:10.5812/ijem.12871
NLM
Cavalheiro BG, Leite AKN, Matos LL de, Miazaki AP, Ientile JM, Kulcsar MAV, Cernea CR. Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center [Internet]. International journal of endocrinology and metabolism. 2018 ; 16( 1):[citado 2024 jun. 30 ] Available from: https://doi.org/10.5812/ijem.12871
Vancouver
Cavalheiro BG, Leite AKN, Matos LL de, Miazaki AP, Ientile JM, Kulcsar MAV, Cernea CR. Malignancy Rates in Thyroid Nodules Classified as Bethesda Categories III and IV: Retrospective Data from a Tertiary Center [Internet]. International journal of endocrinology and metabolism. 2018 ; 16( 1):[citado 2024 jun. 30 ] Available from: https://doi.org/10.5812/ijem.12871
Artigo de periodico
Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection (2017)
Teixeira Junior, Frederico Jose Ribeiro; Couto Netto, Sergio Dias do; Perina, André Luis de Freitas; Torricelli, Fabio C. M; Teixeira, Luciana Ragazzo; Zerati, Antonio Eduardo; Ferreira, Fabio de Oliveira; Akaishi, Eduardo Hiroshi; Nahas, William Carlos; Utiyama, Edivaldo Massazo
Fonte: Oncology letters. Unidade: FM
Assuntos: SARCOMA, VEIA CAVA, NEOPLASIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TEIXEIRA JUNIOR, Frederico Jose Ribeiro et al. Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection. Oncology letters, v. 14, n. 4, p. 3909-3916, 2017Tradução . . Disponível em: https://doi.org/10.3892/ol.2017.6706. Acesso em: 30 jun. 2024.
APA
Teixeira Junior, F. J. R., Couto Netto, S. D. do, Perina, A. L. de F., Torricelli, F. C. M., Teixeira, L. R., Zerati, A. E., et al. (2017). Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection. Oncology letters, 14( 4), 3909-3916. doi:10.3892/ol.2017.6706
NLM
Teixeira Junior FJR, Couto Netto SD do, Perina AL de F, Torricelli FCM, Teixeira LR, Zerati AE, Ferreira F de O, Akaishi EH, Nahas WC, Utiyama EM. Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection [Internet]. Oncology letters. 2017 ; 14( 4): 3909-3916.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3892/ol.2017.6706
Vancouver
Teixeira Junior FJR, Couto Netto SD do, Perina AL de F, Torricelli FCM, Teixeira LR, Zerati AE, Ferreira F de O, Akaishi EH, Nahas WC, Utiyama EM. Leiomyosarcoma of the inferior vena cava: Survival rate following radical resection [Internet]. Oncology letters. 2017 ; 14( 4): 3909-3916.[citado 2024 jun. 30 ] Available from: https://doi.org/10.3892/ol.2017.6706
Artigo de periodico
Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer (2017)
Silvério, Renata; Lira, Fábio S; Oyama, Lila M; Nascimento, Cláudia M. Oller do; Otoch, José Pinhata; Alcântara, Paulo S. M; Batista Junior, Miguel L; Seelander, Marilia Cerqueira Leite
Fonte: Lipids in health and disease. Unidades: FM, HU, ICB
Assuntos: GORDURAS, LIPÍDEOS, NEOPLASIAS, PROTEÍNAS, CAQUEXIA, GORDURAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SILVÉRIO, Renata et al. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer. Lipids in health and disease, v. 16, p. 159, 2017Tradução . . Disponível em: https://doi.org/10.1186/s12944-017-0547-x. Acesso em: 30 jun. 2024.
APA
Silvério, R., Lira, F. S., Oyama, L. M., Nascimento, C. M. O. do, Otoch, J. P., Alcântara, P. S. M., et al. (2017). Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer. Lipids in health and disease, 16, 159. doi:10.1186/s12944-017-0547-x
NLM
Silvério R, Lira FS, Oyama LM, Nascimento CMO do, Otoch JP, Alcântara PSM, Batista Junior ML, Seelander MCL. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer [Internet]. Lipids in health and disease. 2017 ; 16 159.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12944-017-0547-x
Vancouver
Silvério R, Lira FS, Oyama LM, Nascimento CMO do, Otoch JP, Alcântara PSM, Batista Junior ML, Seelander MCL. Lipases and lipid droplet-associated protein expression in subcutaneous white adipose tissue of cachectic patients with cancer [Internet]. Lipids in health and disease. 2017 ; 16 159.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12944-017-0547-x
Artigo de periodico
Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway (2017)
Alves, Michele Joana; Figuerêdo, Raquel Galvão; Azevedo, Flavia Figueiredo; Cavallaro, Diego Alexandre; Pinto Neto, Nelson Inácio; Lima, Joanna Darck Carola; Matos-Neto, Emidio; Radloff, Katrin; Riccardi, Daniela Mendes; Camargo, Rodolfo Gonzalez; Alcântara, Paulo Sérgio Martins de; Otoch, José Pinhata; Batista Junior, Miguel Luiz; Seelaender, Marília
Fonte: BMC Cancer. Unidades: FM, HU, ICB
Assuntos: TECIDO ADIPOSO, NEOPLASIAS, SINAIS E SINTOMAS, IMUNOHISTOQUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALVES, Michele Joana et al. Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway. BMC Cancer, v. 17, n. 190, p. 12 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s12885-017-3178-8. Acesso em: 30 jun. 2024.
APA
Alves, M. J., Figuerêdo, R. G., Azevedo, F. F., Cavallaro, D. A., Pinto Neto, N. I., Lima, J. D. C., et al. (2017). Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway. BMC Cancer, 17( 190), 12 . doi:10.1186/s12885-017-3178-8
NLM
Alves MJ, Figuerêdo RG, Azevedo FF, Cavallaro DA, Pinto Neto NI, Lima JDC, Matos-Neto E, Radloff K, Riccardi DM, Camargo RG, Alcântara PSM de, Otoch JP, Batista Junior ML, Seelaender M. Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway [Internet]. BMC Cancer. 2017 ; 17( 190): 12 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12885-017-3178-8
Vancouver
Alves MJ, Figuerêdo RG, Azevedo FF, Cavallaro DA, Pinto Neto NI, Lima JDC, Matos-Neto E, Radloff K, Riccardi DM, Camargo RG, Alcântara PSM de, Otoch JP, Batista Junior ML, Seelaender M. Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway [Internet]. BMC Cancer. 2017 ; 17( 190): 12 .[citado 2024 jun. 30 ] Available from: https://doi.org/10.1186/s12885-017-3178-8
Artigo de periodico
Lymph node flap transfer for patients with secondary lower limb lymphedema (2017)
Batista, Bernardo N.; Germain, Michel; Faria, José Carlos M.; Becker, Corinne
Fonte: Microsurgery. Unidade: FM
Assuntos: MEMBROS INFERIORES, PROCEDIMENTOS CIRÚRGICOS RECONSTRUTIVOS, NEOPLASIAS, LINFODEMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA, Bernardo N. et al. Lymph node flap transfer for patients with secondary lower limb lymphedema. Microsurgery, v. 37, n. 1, p. 29-33, 2017Tradução . . Disponível em: http://onlinelibrary.wiley.com/doi/10.1002/micr.22404/epdf. Acesso em: 30 jun. 2024.
APA
Batista, B. N., Germain, M., Faria, J. C. M., & Becker, C. (2017). Lymph node flap transfer for patients with secondary lower limb lymphedema. Microsurgery, 37( 1), 29-33. doi:10.1002/micr.22404
NLM
Batista BN, Germain M, Faria JCM, Becker C. Lymph node flap transfer for patients with secondary lower limb lymphedema [Internet]. Microsurgery. 2017 ; 37( 1): 29-33.[citado 2024 jun. 30 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/micr.22404/epdf
Vancouver
Batista BN, Germain M, Faria JCM, Becker C. Lymph node flap transfer for patients with secondary lower limb lymphedema [Internet]. Microsurgery. 2017 ; 37( 1): 29-33.[citado 2024 jun. 30 ] Available from: http://onlinelibrary.wiley.com/doi/10.1002/micr.22404/epdf
Artigo de periodico
Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development (2016)
Meara, John G.; Leather, Andrew J. M.; Hagander, Lars; Alkire, Blake C.; Alonso, Nivaldo; Ameh, Emmanuel A.; Bickler, Stphen W.; Conteh, Lesong; Dare, Anna J.; Davies, Justine; Mérisier, Eunice Dérivois; El-Halabi, Shenaaz; Farmer, Paul E.; Gawande, Atul; Gillies, Rowan; Greenberg, Sarah L. M.; Gruen, Russell L.; Ismail, Edna Adan; Kamara, Thaim Buya; Lavy, Chris; Ludeng, Ganbold; Mkandawire, Nyengo C.; Paykar, Nakul P.; Riesel, Johanna N.; Rodas, Edgar; Rose, John; Roy, Nobhojit; Shrime, Mark G.; Sullivan, Richard; Verguet, Stéphane; Weiser, Thomas G.; Wilson, Iain H.; Yamey, Gavin
Fonte: International journal of obstetric anesthesia. Unidade: FM
Assuntos: SAÚDE MUNDIAL, NEOPLASIAS, CUSTOS DOS CUIDADOS DE SAÚDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MEARA, John G. et al. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. International journal of obstetric anesthesia, v. 25, p. 75-78, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ijoa.2015.09.006. Acesso em: 30 jun. 2024.
APA
Meara, J. G., Leather, A. J. M., Hagander, L., Alkire, B. C., Alonso, N., Ameh, E. A., et al. (2016). Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development. International journal of obstetric anesthesia, 25, 75-78. doi:10.1016/j.ijoa.2015.09.006
NLM
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Gruen RL, Ismail EA, Kamara TB, Lavy C, Ludeng G, Mkandawire NC, Paykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Weiser TG, Wilson IH, Yamey G. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. International journal of obstetric anesthesia. 2016 ; 25 75-78.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.ijoa.2015.09.006
Vancouver
Meara JG, Leather AJM, Hagander L, Alkire BC, Alonso N, Ameh EA, Bickler SW, Conteh L, Dare AJ, Davies J, Mérisier ED, El-Halabi S, Farmer PE, Gawande A, Gillies R, Greenberg SLM, Gruen RL, Ismail EA, Kamara TB, Lavy C, Ludeng G, Mkandawire NC, Paykar NP, Riesel JN, Rodas E, Rose J, Roy N, Shrime MG, Sullivan R, Verguet S, Weiser TG, Wilson IH, Yamey G. Global surgery 2030: evidence and solutions for achieving health, welfare, and economic development [Internet]. International journal of obstetric anesthesia. 2016 ; 25 75-78.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.ijoa.2015.09.006
Artigo de periodico
Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients (2013)
Batista Jr., M. L.; Olivan, M.; Alcantara, P. S. M.; Sandoval, R.; Peres, S. B.; Neves, R. X.; Silverio, R.; Maximiano, L. F.; Otoch, J. P.; Seelaender, Marília Cerqueira Leite
Fonte: Cytokine. Unidades: HU, FM, ICB
Assuntos: TECIDO ADIPOSO, NEOPLASIAS, INFLAMAÇÃO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BATISTA JR., M. L. et al. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine, v. 61, n. 2, p. 532-539, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.cyto.2012.10.023. Acesso em: 30 jun. 2024.
APA
Batista Jr., M. L., Olivan, M., Alcantara, P. S. M., Sandoval, R., Peres, S. B., Neves, R. X., et al. (2013). Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients. Cytokine, 61( 2), 532-539. doi:10.1016/j.cyto.2012.10.023
NLM
Batista Jr. ML, Olivan M, Alcantara PSM, Sandoval R, Peres SB, Neves RX, Silverio R, Maximiano LF, Otoch JP, Seelaender MCL. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients [Internet]. Cytokine. 2013 ; 61( 2): 532-539.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.cyto.2012.10.023
Vancouver
Batista Jr. ML, Olivan M, Alcantara PSM, Sandoval R, Peres SB, Neves RX, Silverio R, Maximiano LF, Otoch JP, Seelaender MCL. Adipose tissue-derived factors as potential biomarkers in cachectic cancer patients [Internet]. Cytokine. 2013 ; 61( 2): 532-539.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.cyto.2012.10.023
Artigo de periodico
Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis (2009)
Sá, Vanessa K. de; Canavez, Flávio C.; Silva, Iran A.; Srougi, Miguel; Leite, Katia R. M.
Fonte: Urologic and oncology. Unidade: FM
Assuntos: NEOPLASIAS, QUIMIOMETRIA, BEXIGA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SÁ, Vanessa K. de et al. Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis. Urologic and oncology, v. 27, n. 4, p. 377-381, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.urolonc.2008.03.016. Acesso em: 30 jun. 2024.
APA
Sá, V. K. de, Canavez, F. C., Silva, I. A., Srougi, M., & Leite, K. R. M. (2009). Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis. Urologic and oncology, 27( 4), 377-381. doi:10.1016/j.urolonc.2008.03.016
NLM
Sá VK de, Canavez FC, Silva IA, Srougi M, Leite KRM. Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis [Internet]. Urologic and oncology. 2009 ; 27( 4): 377-381.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.urolonc.2008.03.016
Vancouver
Sá VK de, Canavez FC, Silva IA, Srougi M, Leite KRM. Isoforms of hyaluronidases can be a predictor of a prostate cancer of good prognosis [Internet]. Urologic and oncology. 2009 ; 27( 4): 377-381.[citado 2024 jun. 30 ] Available from: https://doi.org/10.1016/j.urolonc.2008.03.016

Unidades USP

ReP

Filtros

Tipo de material

Unidades USP

Departamento

Autores

Autores USP

Ano de publicação

Assuntos

Título da fonte

Editora

Nome do evento

País de publicação

Agência de fomento

Indexado em

Afiliação dos autores externos não normalizada

País das instituições de afiliação dos autores externos